Thalidomide, propargyl

CAS : 2098487-39-7

Ref. 3D-YID48739

Informations sur le produit

• Nom: Thalidomide, propargyl
• Marque: Biosynth
• Description: Thalidomide, propargyl is a derivative of the drug thalidomide, which is a synthetic immunomodulatory compound originally developed for its sedative and antiemetic properties. This molecule is sourced from chemical modifications of thalidomide, incorporating a propargyl group to enhance its biological activity profile. Its mode of action involves the modulation of immune responses, inhibition of angiogenesis, and possibly the epigenetic regulation of target genes. Thalidomide, propargyl exhibits potential applications in cancer therapy, owing to its ability to impact tumor microenvironments, specifically by inhibiting the formation of new blood vessels that are essential for tumor growth and survival. It serves as a significant focus in medicinal chemistry for the development of novel therapeutic agents aimed at combating malignancies and providing insights into the mechanisms of action of thalidomide analogs.

Propriétés chimiques

• Masse moléculaire: 312.28 g/mol
• Formule: C₁₆H₁₂N₂O₅
• Degré de pureté: Min. 95%